Changes in antimicrobial resistance of staphylococci isolated from bloodstream infection and the impact of COVID-19.

Publication date: Jul 08, 2026

To analyze the changes in antimicrobial resistance of Staphylococcus aureus (S. aureus) and coagulase-negative staphylococci (CoNS) in bloodstream infections (BSIs) between 2018 and 2024, and to assess temporal associations with the COVID-19 pandemic. A total of 575 S. aureus and 1,014 CoNS isolates from blood cultures were retrospectively reviewed. To define true CoNS BSI, we applied clinical criteria (≥ 2 positive bottles with same species, or 1 positive bottle with clinical signs + central line + targeted therapy). Demographic characteristics and resistance rates to 15 antimicrobial agents were compared using chi-square (χ) and Mann-Kendall tests, with 95% confidence intervals (CIs) and Bonferroni correction for multiple comparisons. CoNS infections were more common in minors (0-17 years: 31. 3%) and the elderly (≥ 80 years: 13. 7%), while S. aureus predominated in adults 18-65 years (51. 8%). CoNS exhibited higher resistance rates than S. aureus to oxacillin (75. 2% vs. 30. 5%, p 

Open Access PDF

Concepts Keywords
Antimicrobial resistance
Bloodstream infection
Coagulase-negative staphylococci
COVID-19
Staphylococcus aureus
Trend analysis

Semantics

Type Source Name
disease MESH bloodstream infection
disease MESH COVID-19
disease MESH infections
drug DRUGBANK Oxacillin
disease MESH Infectious Diseases
disease MESH Dis
pathway REACTOME Reproduction
disease MESH included
drug DRUGBANK Ciprofloxacin
drug DRUGBANK Erythromycin
drug DRUGBANK Meticillin
drug DRUGBANK Clindamycin
drug DRUGBANK Linezolid
drug DRUGBANK Vancomycin
drug DRUGBANK Tigecycline
disease MESH community acquired infections
disease MESH strains
disease MESH TOF
drug DRUGBANK Nitrofurantoin
drug DRUGBANK Levofloxacin
drug DRUGBANK Quinupristin
drug DRUGBANK Dalfopristin
drug DRUGBANK Gentamicin
disease MESH bacteremia
disease MESH staphylococcal infections
drug DRUGBANK Folic Acid
drug DRUGBANK Coenzyme M
disease MESH neonatal sepsis
disease MESH MAE
disease MESH Ocular Infections
disease MESH Dar

Original Article

(Visited 2 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *